Peptide-Based Vaccines

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: 28 February 2025 | Viewed by 29

Special Issue Editors


E-Mail Website
Guest Editor
Institute for Molecular Bioscience, The University of Queensland, Brisbane, Australia
Interests: peptide-based vaccines; gene delivery; medicinal chemistry; organic synthesis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia
Interests: vaccines and nanomedicine; vaccine design; nanotechnology; peptide chemistry; medicinal chemistry; vaccine/drug delivery; antimicrobial agents; macromolecules; adjuvants; immunology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Australia
Interests: preclinical formulation development; vaccines; nanotechnology; vaccine delivery systems; drug delivery systems; peptide-based vaccines; proteins; pharmaceutical sciences; pharmacokinetics; in vivo–in vitro correlations; pulmonary delivery; vaccine adjuvant development

Special Issue Information

Dear Colleagues,

The journey of immunization has evolved significantly from the use of whole organisms to the precise targeting of specific pathogenic interactions via peptide-based vaccines. These innovative vaccines leverage minimal antigenic epitopes to provoke targeted immune responses, thus sidestepping the broader implications of traditional vaccine strategies that often incorporate entire pathogens.

Peptide-based vaccines stand at the frontier of immunology, combining synthetic precision with the vast capabilities of the human immune system. This approach minimizes adverse effects and maximizes efficacy, allowing for the development of vaccines that are not only more specific but also potentially more effective in managing resistance and variations in pathogens.

In this Special Issue, we invite contributions that explore the full spectrum of peptide-based vaccine development—from theoretical designs and mechanistic insights to clinical evaluations and therapeutic applications. Studies that shed light on the intricate interplay between these vaccines and the immune system, offering new perspectives on enhancing immune responses or evading pathogenic resistance, are particularly welcome.

We look forward to your insightful contributions that push the boundaries of vaccine science and open new doors to immunological protection and intervention.

Dr. Waleed Hussein
Dr. Mariusz Skwarczynski
Dr. Ahmed O. Shalash
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • peptide-based vaccines
  • infectious diseases
  • prophylactic vaccines
  • therapeutic vaccines
  • cancer
  • vaccine formulations
  • adjuvants

Published Papers

This special issue is now open for submission.
Back to TopTop